Skip to main content
SATURDAY,
MAY 28, 2022
SATURDAY,
MAY 28, 2022
Home
Economy
Stocks
Analysis
World+Biz
Sports
Splash
Features
Videos
Long Read
Games
Epaper
More
COVID-19
Bangladesh
Infograph
Interviews
Offbeat
Thoughts
Podcast
Quiz
Tech
Subscribe
Archive
Trial By Trivia
Magazine
Supplement
বাংলা
Serum Institute of India (SII)
Global Economy
Indian vaccine giant Serum plans African plant in global expansion
Coronavirus chronicle
Omicron-specific booster shot possible: SII CEO Adar Poonawalla
Coronavirus chronicle
Serum Institute to resume supply of Covishield to Covax: Reports
South Asia
India rules out reducing gap between Covishield doses
Coronavirus chronicle
India allows Serum Institute to enrol 7-11 year olds in Novavax Covid-19 vaccine trial
Coronavirus chronicle
India's Serum Institute to invest $68 million in UK vaccine maker Oxford Biomedica
Covid-19 in Bangladesh
Bangladesh to get vaccines from India soon: Doraiswami
Bangladesh
SII must return money if they fail to deliver vaccines: Health minister
World+Biz
Serum Institute of India to manufacture Sputnik V starting September
Coronavirus chronicle
India raises Covid vaccine production amid sharp dip in cases
Coronavirus chronicle
SII seeks EU travel approval for its Covishield vaccine
Coronavirus chronicle
SII to introduce Novavax vaccine in India by September
Coronavirus chronicle
Novavax vaccine efficacy data promising; trials in advanced stage: Indian govt
Show More